Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission. Frisch A, Ganzel C, Ofran Y, Krayem B, et al. Eur J Haematol 2025;114:641-649.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frisch A, Ganzel C, Ofran Y, Krayem B, et al. Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission. Eur J Haematol 2025;114:641-649.
PMID: 39740005